Skip to main content

Advertisement

SpringerLink
Log in

ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report

  • Report
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Purpose

Previously, the engulfment and cell motility 3 (ELMO3) protein has been reported to be involved in cell migration and cytoskeletal remodeling. As of yet, nothing is known about the role of ELMO3 in head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to asses ELMO3 expression in postoperatively irradiated HNSCC patients and to evaluate a possible correlation between this expression and patient survival.

Methods

125 postoperatively irradiated HNSCC patients were included in this study. ELMO3 expression was assessed using immunohistochemistry (IHC). The expression of ELMO3 in the respective HNSCC tumor tissues and its lymph node metastases was correlated with patient survival using Kaplan-Meier curve analyses.

Results

Through IHC, ELMO3 expression was detected in 71.2% of the HNSCC cases tested. We found significantly increased overall and disease-free survival rates and decreased recurrence rates in patients with no detectable ELMO3 expression. In reverse, we found that ELMO3 expression served as an independent marker for a decreased overall and disease-free survival.

Conclusion

Our data indicate that in the surgically treated and postoperatively irradiated patients tested, ELMO3 expression serves as a predictive marker for reduced survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. R. Siegel, J. Ma, Z. Zou, A. Jemal, Cancer statistics, 2014. CA Cancer J. Clin. 64, 9–29 (2014)

    Article  PubMed  Google Scholar 

  2. R.J. Baatenburg de Jong, J. Hermans, J. Molenaar, J.J. Briaire, S. le Cessie, Prediction of survival in patients with head and neck cancer. Head Neck 23, 718–724 (2001)

    Article  CAS  PubMed  Google Scholar 

  3. D.H. Lee, M.J. Kim, J.L. Roh, S.B. Kim, S.H. Choi, S.Y. Nam, S.Y. Kim, Distant metastases and survival prediction in head and neck squamous cell carcinoma. Otolaryngol. Head Neck Surg. 147, 870–875 (2012)

    Article  PubMed  Google Scholar 

  4. E.A. Sisk, S.G. Soltys, S. Zhu, S.G. Fisher, T.E. Carey, C.R. Bradford, Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 24, 841–849 (2002)

    Article  PubMed  Google Scholar 

  5. I.P. Ribeiro, F. Caramelo, F. Marques, A. Domingues, M. Mesquitam, L. Barroso, H. Prazeres, M.J. Juliao, I.P. Baptista, A. Ferreira, J. Barbosa Melo, I. Marques Carreira, WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report. Cell. Oncol. 39, 573–558 (2016)

    Article  CAS  Google Scholar 

  6. B. Jang, J.A. Shin, Y.X. Kim, J.Y. Kim, H.K. Yi, I.S. Park, N.P. Cho, S.D. Cho, Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells. Cell. Oncol. 39, 79–87 (2016)

    Article  CAS  Google Scholar 

  7. Y. You, W. Yng, X. Qi, F. Wang, H. Li, C. Lin, W. Li, C. Gu, Y. Zhang, Y. Ran, CRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma. Cell. Oncol. 38, 205–214 (2015)

    Article  CAS  Google Scholar 

  8. M.-A. Goyette, J.-F. Côté, NSCLC metastasis: going with ELMO3. Oncotarget 5, 5850 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  9. M. Patel, T.C. Chiang, V. Tran, F.J.S. Lee, J.F. Cote, The Arf family GTPase Arl4A complexes with ELMO proteins to promote actin cytoskeleton remodeling and reveals a versatile Ras-binding domain in the ELMO proteins family. J. Biol. Chem. 286, 38969–38979 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. L.S. Kristensen, S. Søes, L.L. Hansen, ELMO3: a direct driver of cancer metastasis? Cell Cycle 13, 2483–2484 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. S. Søes, I.L. Daugaard, B.S. Sørensen, A. Carus, M. Mattheisen, J. Alsner, J. Overgaard, H. Hager, L.L. Hansen, L.S. Kristensen, Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation. Oncoscience 1, 367 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  12. M. Coskun, M. Boyd, J. Olsen, J.T. Troelsen, Control of intestinal promoter activity of the cellular migratory regulator gene ELMO3 by CDX2 and SP1. J. Cell. Biochem. 109, 1118–1128 (2010)

    CAS  PubMed  Google Scholar 

  13. L. Kadletz, J. Bigenzahn, D. Thurnher, I. Stanisz, B.M. Erovic, S. Schneider, R. Schmid, R. Seemann, P. Birner, G. Heiduschka, Evaluation of polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma. Head Neck 38, E1918–E1925 (2015)

    Article  PubMed  Google Scholar 

  14. G. Heiduschka, A. Grah, F. Oberndorfer, L. Kadletz, G. Altorjai, G. Kornek, F. Wrba, D. Thurnher, E. Selzer, Verbessertes Überleben von HPV/p16-positiven Oropharynxkarzinompatienten mit postoperativer Bestrahlung. Strahlenther. Onkol. 191, 209–216 (2014)

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was not funded by a third party.

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, Head and Neck Surgery, Medical University Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria

    Lorenz Kadletz, Gregor Heiduschka, Ulana Kotowski, Georg Haymerle & Markus Brunner

  2. Department of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria

    Robert Wiebringhaus, Elisabeth Gurnhofer & Lukas Kenner

  3. Department of Oral and Maxillofacial Surgery, National Maxillofacial Unit, St James’s Hospital, and Dublin Dental University Hospital, Dublin, Ireland

    Conor Barry

  4. Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria

    Lukas Kenner

  5. Institute of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria

    Lukas Kenner

Authors
  1. Lorenz Kadletz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregor Heiduschka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Wiebringhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisabeth Gurnhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ulana Kotowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Georg Haymerle
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Markus Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Conor Barry
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lukas Kenner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregor Heiduschka.

Ethics declarations

Conflict of Interest

All authors declare to have no conflict of interest.

Electronic supplementary material

ESM 1

(DOCX 61 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kadletz, L., Heiduschka, G., Wiebringhaus, R. et al. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report. Cell Oncol. 40, 193–198 (2017). https://doi.org/10.1007/s13402-016-0310-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-016-0310-8

Keywords

Search

Navigation